Crystalline forms of (R)-8-chloro-1-methyl2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride

Details for Australian Patent Application No. 2005318959 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Henshilwood, James A.; Agarwal, Rajesh Kumar; Post, Noah; Betts, III, William L.; Kiang, Yuan-Hon

Agent FB Rice

Pub. Number AU-B-2005318959

PCT Pub. Number WO2006/069363

Priority 60/638,221 21.12.04 US

Filing date 20 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 15 December 2011

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/069363 Priority application(s): WO2006/069363

15 December 2011 Application Accepted

  Published as AU-B-2005318959

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318968-Method and apparatus to hydraulically bypass a well tool

2005318958-Stabilized iodocarbon compositions